Chorionic villus sampling (CVS) is a prenatal test used to detect genetic abnormalities in a developing fetus. It involves taking a small sample of cells from the placenta, specifically the chorionic villi, which are tiny finger-like projections on the surface of the placenta.
CVS is typically recommended for women who are at increased risk of having a baby with a genetic condition, such as women who are over the age of 35, have a family history of genetic disorders, or have had an abnormal result on a previous prenatal test.
The procedure is typically done between 10 and 13 weeks of pregnancy and involves either inserting a needle through the mother’s abdomen or inserting a thin tube through the cervix. The sample of chorionic villi is then extracted and sent to a laboratory for genetic testing.
There are two types of CVS: transabdominal CVS, which is performed through the abdomen, and transcervical CVS, which is performed through the cervix. Transabdominal CVS is the more common of the two and is usually done under ultrasound guidance to ensure the needle is inserted in the correct location.
While CVS is a highly accurate test, with a detection rate of over 99%, it does carry some risks. There is a small risk of miscarriage, estimated to be about 0.5-1%, and a risk of infection. In addition, there is a small risk of limb abnormalities in the fetus, particularly if the procedure is performed before 10 weeks of pregnancy.
It is important for women to discuss the risks and benefits of CVS with their healthcare provider before undergoing the procedure. In some cases, alternative tests, such as amniocentesis or noninvasive prenatal testing, may be recommended instead.
In conclusion, chorionic villus sampling is a prenatal test used to detect genetic abnormalities in a developing fetus. While it is a highly accurate test, it does carry some risks and should only be performed after careful consideration of the benefits and potential harms.
